
Coinbase breach: Two TaskUs India staffers accessed customer data
The cryptocurrency exchange utilises TaskUs to provide outsourced customer service support from personnel located in India.
Coinbase stated in the US SEC filing that the incident did not involve the compromise of passwords or private keys, and at no time were any of the targeted contractors or employees able to access customer funds. While the company is still investigating, the affected data included names, addresses, phone numbers, and emails, masked social security, govt ID images, and account data.
The security breach was referenced by plaintiff Nelson Estrada, who lodged a complaint in a US court against TaskUs, alleging the company's failure to protect personal identification details of himself and millions of other individuals. Coinbase disclosed in a regulatory filing that it received email communication from an unknown threat actor claiming to have obtained information about certain Coinbase customer accounts, as well as internal Coinbase documentation, including materials relating to customer service and account-management systems.
The threat actor, the filing said, appears to have obtained this information by paying multiple contractors or employees working in support roles outside the United States to collect information from internal Coinbase systems to which they had access.
According to a complaint, Coinbase said the preliminarily estimated expenses to be within the range of approximately $180 million to $400 million relating to remediation costs and voluntary customer reimbursements relating to this incident.
When TOI reached out to TaskUs, the company said, "Early this year, we identified two individuals who illegally accessed information from one of our clients. We believe these two individuals were recruited by a much broader, coordinated criminal campaign against this client that also impacted a number of other providers servicing this client.
" TaskUs said it immediately reported this activity to the client, terminated the individuals involved, and is coordinating with law enforcement.
"Out of an abundance of caution, TaskUs ceased all Coinbase operations in Indore in early January, impacting 226 teammates. Following the investigation, all teammates, excluding the two bad actors, were offered a generous severance package, including six months of pay." TaskUs said, "We place the highest priority on safeguarding the data of our clients and their customers and continue to strengthen our global security protocols and training programmes, including by investing millions of additional dollars in physical and information security."
When TOI reached out to Coinbase, a spokesperson for the company said, "As we've already disclosed, we recently discovered that a threat actor solicited overseas agents to capture customer account information dating back to December 2024. We notified affected users and regulators, cut ties with the TaskUs personnel involved and other overseas agents, and tightened controls. No passwords, private keys, or any other information that would allow someone to directly access customer accounts or funds were exposed, and Coinbase Prime accounts are untouched.
"

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)

Business Standard
21 minutes ago
- Business Standard
Beauty unicorn Good Glamm Group struggles to pay staff amid cash crunch
The Mumbai-based company has delayed employee salaries while seeking new funding, as three board directors from major VCs recently departed Bengaluru Listen to This Article Beauty unicorn Good Glamm Group is struggling to pay staff salaries amid a severe cash crunch that had prompted three board directors to exit, according to people familiar with the company's finances. 'There is no money in the bank and the company is not able to pay salaries to the employees,' said one person with direct knowledge of the situation. The firm is actively scouting for investors to raise around ₹200 crore to ₹250 crore to stay afloat. The financial crisis had led to the departure of three high-profile board members early this year. Anand Daniel, partner at Accel, Vishal


Indian Express
23 minutes ago
- Indian Express
Dubai eyes air taxi launch in 2026 after successful test flight
Dubai could soon transform daily commuting with the introduction of air taxis. California-based Joby Aviation successfully conducted the first test flight of its fully-electric aerial taxi in the emirate this week. The demonstration marks a critical step in Dubai's plan to integrate electric vertical takeoff and landing (eVTOL) aircraft into the city's mobility network by 2026. Joby Aviation aims to help ease the burden on Dubai's increasingly congested roads by offering a faster, eco-friendly alternative for short-distance travel. 'We want to change the way people commute,' Reuters quoted Anthony Khoury, Joby's UAE General Manager, as saying. According to the company, a trip from Dubai International Airport (DXB) to Palm Jumeirah using its aerial taxi will take just 12 minutes—compared to approximately 45 minutes by car. The future of cleaner, quieter urban travel just landed in Dubai. Today marks a significant milestone on our path to commercialization: we successfully completed a series of piloted, full-transition, electric vertical-takeoff-and-landing flights in — Joby Aviation (@jobyaviation) June 30, 2025 Earlier in 2024, Joby signed an exclusive six-year contract with Dubai's Roads and Transit Authority (RTA) to operate aerial taxis in the emirate. The commercial rollout, expected in 2026, will initially connect four vertiport hubs—Dubai International Airport, Palm Jumeirah, Dubai Downtown, and Dubai Marina. While affordability remains a long-term goal, Khoury acknowledged that the initial pricing structure may cater more to high-income travelers. 'As with any novel technology, early days might be a bit more premium,' he said. The test flight was held on Monday at a remote desert site southeast of Dubai's downtown. Designed to simulate a typical passenger route, the electric aircraft executed a vertical takeoff, flew several miles, and returned with a vertical landing. The event was attended by senior government officials, transport executives, and Joby Aviation representatives. The Joby Aerial Taxi is capable of flying up to 160 km at speeds reaching 320 kmph. With zero operating emissions, the fully-electric eVTOL is designed for minimal noise, making it ideal for urban use. 'It will be flying in the city, next to residential areas, and hopefully people will barely notice it,' Khoury noted. Despite the progress, the eVTOL industry still faces challenges such as regulatory approvals and infrastructure development, particularly the construction of vertiports. In April, Morgan Stanley downgraded Joby's stock price target from $10 to $7 due to execution risks and industry-wide concerns like supply-chain disruptions and tariffs. Joby shares currently trade at $10.55, according to Reuters.


Indian Express
28 minutes ago
- Indian Express
After probe report on financial irregularities, all but one clinical trials cancelled at Ahmedabad Hospital
When the investigation into the alleged financial irregularities in clinical trials at an Ahmedabad-based government hospital began, 10 trials were underway at the hospital while seven, for which agreements had been signed, were yet to begin. With the irregularities coming to light, all the clinical trials that were in their initial phases were shut down, while those that were yet to begin were cancelled, said a senior official of the Ahmedabad Municipal Corporation (AMC). As of now, only one clinical trial is underway at the Sheth Vadilal Sarabhai General Hospital, Medical Superintendent Dr Parul Shah confirmed with The Indian Express. Meanwhile, at least four to five doctors accused in the scam have returned the amount deposited in their bank accounts, said Dr Shah. 'We have sent the doctors notices that as per the report, we need to recover the money they received directly for the clinical trials. At least 4-5 doctors have already paid back the amount. The rest are also going to pay us back,' said Dr Shah. When asked if the hospital would conduct more trials in the coming days, an official said, 'We have decided to not do any clinical trials at the moment till all these irregularities are sorted out.' As reported by The Indian Express on July 1, a probe panel in Gujarat found financial irregularities in about 65 human clinical trials conducted at the hospital run by the AMC, where 15 doctors allegedly diverted at least Rs 1.87 crore directly to their personal accounts from 2021 — money that should have gone to the hospital first, according to a senior official. It has now also been learnt that the Drugs Controller General of India (DCGI) has asked the hospital not to conduct any more trials without proper standard operating procedures and permissions. The clinical trials that the hospital was conducting included those of drugs and formulations from 34 different pharmaceutical companies and clinical research companies (CROs), and were being managed by up to eight Site Management Organisations (SMOs). Of the 65 trials, a total of 48 had been completed, 10 were underway and seven were yet to begin, for which agreements had been signed. However, according to hospital officials, currently, only one trial is still underway. An official from the AMC Medical Education Trust (AMCMET) said, 'We had stopped most of the clinical trials that were in their initial phases before the investigation began. Only one trial is underway and we will complete that trial in the interest of the patients. No patients have had to suffer due to the financial irregularities.' Dr Shah said, 'The DCGI team that conducted its investigation here at the hospital said that the clinical trials themselves were conducted in a proper manner. Whatever discrepancies were there, were in the financial aspects. The trials were not compromised.' The DCGI, when it conducted its three-day investigation in May, asked the hospital to immediately stop the trials, form an ethics committee and get it vetted by the authorities if they wanted to conduct more trials, said sources. A total of 15 doctors were alleged to have siphoned off Rs 1.87 crore, proceeds from 58 clinical trials, into their personal bank accounts. Only Rs 10.63 lakh had been found to have been deposited in the account of the hospital. An inquiry committee found that a retired Medical Superintendent, an Associate Professor and 12 contractual doctors had been involved in the alleged scam